Mysimba vs Ozempic UK: Expert Comparison | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Mysimba vs Ozempic: £10 off Your First Order

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £10 off for new customers
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£89.00 From £79.00 £10 discount using discount code Weightlossnew
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £135.00

£36.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £169.00

£44.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £210.00

£55.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £235.00

£61.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £260.00

£67.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £277.00

£71.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £79.00

£22.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £99.00

£27.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £109.00

£29.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £159.00

£42.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £189.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

Start Consultation

Mysimba vs Ozempic: UK Clinical Comparison Guide

When searching for a mysimba vs ozempic uk comparison, understanding the fundamental differences between these weight loss treatments is essential for making an informed choice. Mysimba (naltrexone/bupropion) works through appetite suppression in the central nervous system, whilst Ozempic (semaglutide) mimics natural gut hormones to regulate blood sugar and satiety. At Cured Pharmacy, our UK-registered clinical team can assess which option suits your individual health profile during a free three-minute consultation.

How Mysimba and Ozempic Work Differently

Mysimba contains a combination of naltrexone (an opioid antagonist) and bupropion (an antidepressant), which work together on the hypothalamus and mesolimbic reward system to reduce appetite and food cravings [1]. This dual-action tablet targets brain pathways associated with hunger and reward-driven eating behaviour, making it suitable for patients who struggle with emotional or habitual overeating.

Ozempic, by contrast, contains semaglutide—a GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1, a hormone naturally released after eating [2]. By slowing gastric emptying, enhancing insulin secretion, and acting on brain appetite centres, semaglutide produces profound satiety and sustained weight reduction. The STEP 1 trial demonstrated an average 14.9% body weight reduction over 68 weeks in participants receiving semaglutide 2.4mg weekly [2].

The key mechanistic difference lies in delivery and pathway: Mysimba is an oral tablet taken twice daily that modulates central nervous system neurotransmitters, whilst Ozempic is a once-weekly subcutaneous injection targeting peripheral and central GLP-1 receptors. Both require prescription and clinical assessment by a UK prescriber before dispensing.

Clinical Efficacy: Mysimba vs Ozempic Weight Loss Results

In the COR-I trial, patients taking Mysimba alongside reduced-calorie diet and exercise achieved an average weight loss of 5-6% over 56 weeks, with approximately 50% of participants losing at least 5% of their baseline body weight [1]. Mysimba demonstrates moderate efficacy and is particularly beneficial for individuals who prefer oral medication or have contraindications to injectable treatments.

Semaglutide-based treatments like Ozempic show significantly greater weight reduction in clinical trials. The STEP programme consistently reported average weight loss exceeding 10-15% when used at higher doses licensed for obesity management [2][3]. Patients typically notice appetite suppression within the first week of treatment, with progressive weight reduction over subsequent months as the dose is gradually titrated.

It's important to note that both medications work best when combined with lifestyle modifications including dietary changes and increased physical activity. Your UK prescriber will discuss realistic expectations during your consultation, as individual results vary based on adherence, baseline BMI, metabolic health, and concurrent medical conditions.

Which Treatment Produces Faster Results?

GLP-1 receptor agonists like Ozempic generally produce more rapid initial weight loss compared to Mysimba, with many patients reporting noticeable appetite reduction within 1-2 weeks of starting treatment [2]. Mysimba requires a gradual dose escalation over four weeks and may take 8-12 weeks before significant weight changes become apparent [1]. However, speed of weight loss should not be the sole determining factor—tolerability, administration preference, and your medical history are equally important considerations that your prescriber will evaluate.

Side Effects and Tolerability Comparison

Mysimba's most common side effects include nausea (reported in up to 30% of patients), constipation, headache, vomiting, dizziness, and insomnia [1]. These effects typically diminish after the first month as the body adjusts. Mysimba carries important contraindications including uncontrolled hypertension, seizure disorders, eating disorders, and concurrent use of opioid medications. Blood pressure monitoring is recommended during treatment.

Ozempic and other semaglutide treatments commonly cause gastrointestinal side effects including nausea (affecting 20-40% of users), diarrhoea, constipation, and occasional vomiting, particularly during dose escalation [2][3]. These effects are usually mild to moderate and improve with continued use. Rare but serious risks include pancreatitis, gallbladder disease, and medullary thyroid carcinoma (contraindicated in patients with personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2).

The injection-based delivery of Ozempic eliminates concerns about tablet swallowing but requires patients to be comfortable with weekly subcutaneous injections. Mysimba's oral administration may appeal to those who prefer tablets, though the twice-daily dosing schedule requires consistent adherence. Your UK prescriber will review your complete medical history, current medications, and personal preferences to determine which treatment presents the most favourable benefit-risk profile for your circumstances.

Treatment Active Ingredient Administration Dosing Frequency Average Weight Loss Starting Price
Mysimba Naltrexone/Bupropion Oral tablet Twice daily 5-6% (56 weeks) Varies by pharmacy
Ozempic Semaglutide Subcutaneous injection Once weekly Licensed for diabetes (lower dose) Varies by pharmacy
Wegovy Semaglutide 2.4mg Subcutaneous injection Once weekly 15-17% (68 weeks) From £89.00

Wegovy: The Licensed Semaglutide Option for Weight Management

Whilst Ozempic is licensed in the UK primarily for type 2 diabetes management, Wegovy contains the same active ingredient (semaglutide) but is specifically licensed by the MHRA for chronic weight management in adults with obesity or overweight with weight-related comorbidities [3]. Wegovy delivers higher doses of semaglutide (up to 2.4mg weekly) compared to Ozempic's maximum 1mg dose for diabetes.

At Cured Pharmacy, we offer Wegovy from £79.00 following a free online consultation with our UK-registered prescribers. The consultation takes under three minutes and includes a comprehensive assessment of your BMI, medical history, current medications, and weight loss goals. Wegovy has demonstrated superior weight loss outcomes compared to both Mysimba and diabetes-dose semaglutide in head-to-head trials [3][4].

The STEP clinical programme showed that patients receiving Wegovy 2.4mg achieved an average weight reduction of 15-17% over 68 weeks, with nearly 70% of participants losing at least 10% of their body weight [3]. This represents substantially greater efficacy than Mysimba, though both medications require ongoing treatment to maintain weight loss. Discontinuation typically results in gradual weight regain, emphasising the importance of sustainable lifestyle changes alongside pharmacotherapy.

Why Choose Wegovy Over Ozempic for Weight Loss?

Wegovy is the appropriate choice for weight management because it's specifically licensed for obesity treatment and delivers the evidence-based 2.4mg semaglutide dose proven in weight loss trials [3]. Using Ozempic off-label for weight loss means receiving a lower dose than studied in obesity research. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), ensures all prescriptions align with UK licensing and clinical guidelines, providing you with the correct medication at the appropriate dose for your treatment goals.

Cost Considerations: Mysimba vs Ozempic UK Pricing

Weight loss medication costs vary across UK pharmacies, and understanding the total treatment expense is essential for budgeting ongoing therapy. At Cured Pharmacy, we guarantee the lowest prices in the UK with transparent upfront pricing—you'll see exactly what you'll pay before completing your consultation, with no hidden fees or surprise charges at checkout.

Wegovy is available at Cured Pharmacy from £79.00, representing exceptional value for a licensed, high-dose semaglutide treatment. This competitive pricing includes your medication, UK prescriber assessment, and discreet delivery to your door. We never compromise on quality—all medications are genuine UK-licensed products sourced through regulated channels and dispensed by our GPhC-registered pharmacy (9012511).

Many patients find that the superior efficacy of semaglutide-based treatments provides better value over time compared to less effective alternatives, as achieving your weight loss goals more efficiently may reduce the total duration of treatment required. Your prescriber will discuss treatment duration expectations and ongoing costs during your consultation, ensuring you have complete information to make an informed decision about your weight management journey.

Choosing Between Mysimba and Ozempic: Clinical Considerations

The choice between Mysimba and semaglutide-based treatments depends on multiple clinical factors including your BMI, medical history, medication preferences, and previous weight loss attempts. Mysimba may be more suitable for patients who prefer oral medication, have contraindications to GLP-1 agonists, or have successfully used combination naltrexone/bupropion therapy previously [1].

Semaglutide treatments like Wegovy typically represent the first-line pharmacotherapy option for most patients seeking significant weight reduction, given their superior efficacy in clinical trials and once-weekly dosing convenience [2][3][4]. They're particularly beneficial for individuals with type 2 diabetes or prediabetes, as semaglutide provides additional glycaemic control alongside weight loss benefits.

Our UK-registered clinical team will evaluate your complete medical profile during your free consultation, considering factors such as cardiovascular risk, current medications, mental health history, and personal treatment goals. This individualised assessment ensures you receive the most appropriate prescription for your circumstances. You can start your consultation now at Cured Pharmacy—it takes less than three minutes, and you'll receive a clinical decision within hours.

Starting Your Weight Loss Treatment at Cured Pharmacy

Beginning treatment is straightforward: complete our secure online consultation form, which asks about your height, weight, medical conditions, and current medications. A UK-registered prescriber reviews your submission and determines the most suitable treatment option. If approved, your medication is dispensed by our GPhC-registered pharmacy and delivered in 100% discreet packaging. We're available on (+44) 116 4646009 if you have questions before, during, or after your consultation—our team is here to support your weight management journey every step of the way.

Scientific References

  1. Greenway, F. L., et al. (2010). Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 376(9741), 595-605. https://doi.org/10.1016/S0140-6736(10)60888-4
  2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183
  3. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414-1425. https://doi.org/10.1001/jama.2021.3224
  4. Davies, M., et al. (2021). Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. https://doi.org/10.1016/S0140-6736(21)00213-0

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, lifestyle modifications, and individual metabolic factors.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can I switch from Mysimba to Ozempic or Wegovy?
Yes, you can switch between weight loss treatments under medical supervision. Your UK prescriber will assess your response to Mysimba and determine if transitioning to a GLP-1 treatment like Wegovy would be appropriate. A washout period is not typically required when switching from Mysimba to semaglutide-based medications.
Is Mysimba vs Ozempic a fair comparison for weight loss?
Whilst both are licensed weight management treatments in the UK, they work through entirely different mechanisms and demonstrate different efficacy levels in clinical trials. Wegovy (high-dose semaglutide) is more directly comparable to Mysimba, as both carry specific obesity management licences, whereas Ozempic is primarily licensed for diabetes treatment.
Which is better for weight loss: Mysimba or Ozempic?
Clinical trial data shows semaglutide-based treatments produce significantly greater weight loss than Mysimba on average—approximately 15-17% versus 5-6% body weight reduction respectively. However, 'better' depends on your individual medical profile, preferences, and tolerability, which your UK prescriber will assess during consultation.
Do I need a prescription for Mysimba or Ozempic in the UK?
Yes, both Mysimba and Ozempic are prescription-only medications in the UK and require clinical assessment by a UK-registered prescriber before dispensing. At Cured Pharmacy, this consultation is free and takes under three minutes to complete online.
What are the main side effects of Mysimba vs Ozempic?
Mysimba commonly causes nausea, constipation, headache, and insomnia, particularly during the first month. Ozempic and Wegovy typically cause gastrointestinal effects including nausea, diarrhoea, and constipation, especially during dose escalation. Most side effects diminish with continued use as your body adjusts to treatment.
How long does it take to see results with Mysimba vs Ozempic?
Semaglutide treatments like Ozempic or Wegovy typically produce noticeable appetite suppression within 1-2 weeks, with progressive weight loss over subsequent months. Mysimba requires gradual dose escalation and may take 8-12 weeks before significant weight changes become apparent.
Can I take Mysimba and Ozempic together?
Combining Mysimba with semaglutide treatments is not standard practice and would require careful evaluation by a specialist. Your UK prescriber will recommend the single most appropriate treatment based on your clinical profile rather than combination therapy, as there is limited evidence supporting concurrent use of these medications.
Why is Wegovy recommended instead of Ozempic for weight loss?
Wegovy is specifically licensed by the MHRA for chronic weight management and delivers the 2.4mg semaglutide dose proven in obesity trials, whereas Ozempic is licensed for type 2 diabetes at lower doses. Using the correctly licensed medication at the evidence-based dose ensures you receive optimal treatment aligned with UK prescribing guidelines.